News
Organizational insights and updates
-
Read ArticleDark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance
Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.
-
Read ArticleA new liver cancer trial explores a “two-in-one" treatment approach
Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.
-
Read ArticleProvidence Cancer Institute secures three significant grants
Prestigious grants will help researchers pursue important cancer studies.
-
Read ArticleProvidence delivers $400 million turnaround through the first half of 2026
With Q2 results, Providence surpasses more than a year of profitability, fueled by focused restructuring and operational improvements
-
Read ArticleProvidence and Arizona State University receive Stand Up To Cancer grant to advance next-generation cancer immunotherapy
Grant‑funded collaboration focuses on mRNA vaccine technology to strengthen personalized T‑cell therapies for pancreatic cancer
-
Read ArticleQ&A: Meet one of the investigational drug pharmacists at Providence
An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.
-
Read ArticleNew T-cell therapy for KRAS G12D cancers
An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.
-
Read ArticleProvidence names Brad Myers chief pharmacy officer
Brad Myers, PharmD, MBA, has been named Providence's new chief pharmacy officer.
-
Read ArticleLeadership, empowerment training key to addressing clinician burnout, Providence study shows
Providence study reveals clinician burnout can be successfully addressed with empowerment and well-being leadership development training.
-
Read ArticleAmanda Chawla to join Providence as chief supply chain officer
Amanda Chawla has been named as Providence's chief supply chain officer. Chawla will lead systemwide supply chain strategy and operations, helping strengthen resiliency and improve performance.
-
Read ArticleProvidence nursing leader Mila Sprouse named to esteemed nursing fellowship
Mila Sprouse, chief nursing officer for the North Puget Sound service area, has been named a 2026 fellow with the American Academy of Nursing.
-
Read ArticleWhen standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer
A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.
-
Read ArticleHope comes in a clinical trial: Brad’s remarkable story
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
-
Read ArticleColonoscopies finding a high rate of early onset colorectal cancer, Providence study finds
-
Read ArticleProvidence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma
PSNI collaborates with Seattle-based HDT Bio on preparations for trialing novel treatment to breach blood-brain barrier
-
Read ArticleProvidence's environmental stewardship efforts net Practice Greenhealth’s highest honor
Providence today received a Greenhealth Top Health System Award by Practice Greenhealth. The award is Practice Greenhealth’s highest honor for health systems.
-
Read ArticleProvidence researchers head to Chicago for leading cancer conference
Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.
-
Read ArticleProvidence study finds AI ambient listening tool modestly reduces documentation burden, improves provider efficiency
Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.
-
Read ArticleProvidence study finds low radiation exposure during TAVR procedures, offers reassurance for physicians considering cardiology
Radiation exposure during TAVR procedures was low overall across nearly 9,000 cases performed at Providence from 2018 to 2022, according to a new Providence study.
-
Read ArticleProvidence provides $2.1 billion in community benefit in 2025 to address and respond to the community’s greatest needs
-
Loading More...
